{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:21:44Z","timestamp":1787718104076,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ero.2026.01.014","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T22:11:01Z","timestamp":1771279861000},"page":"234-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7675-4844","authenticated-orcid":false,"given":"Zohra Faizy","family":"Ahmadzay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-9457","authenticated-orcid":false,"given":"Stylianos","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-8482","authenticated-orcid":false,"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-9235","authenticated-orcid":false,"given":"Jette","family":"Heberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-0630","authenticated-orcid":false,"given":"Signe","family":"M\u00f8ller-Bisgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5063-9932","authenticated-orcid":false,"given":"Sara Nysom","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-277X","authenticated-orcid":false,"given":"Simon Horskj\u00e6r","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-841X","authenticated-orcid":false,"given":"Anne Gitte","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-2417","authenticated-orcid":false,"given":"Isabel","family":"Castrejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-6314","authenticated-orcid":false,"given":"Luc\u00eda","family":"Otero-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-6545","authenticated-orcid":false,"given":"Jakub","family":"Z\u00e1vada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-8422","authenticated-orcid":false,"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarno","family":"Rutanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-8439","authenticated-orcid":false,"given":"Laura","family":"Kuusalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-6167","authenticated-orcid":false,"given":"Burkhard","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-1764","authenticated-orcid":false,"given":"Michael J.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-9189","authenticated-orcid":false,"given":"Ziga","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-4016","authenticated-orcid":false,"given":"Katja Perdan","family":"Prikmajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-5465","authenticated-orcid":false,"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-6505","authenticated-orcid":false,"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6751-3330","authenticated-orcid":false,"given":"Gerdur","family":"Grondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8086-9915","authenticated-orcid":false,"given":"Irene","family":"van der Horst-Bruinsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Laas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-2840","authenticated-orcid":false,"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-9946","authenticated-orcid":false,"given":"Catalin","family":"Codreanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-8288","authenticated-orcid":false,"given":"Daniela Di","family":"Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-1369","authenticated-orcid":false,"given":"G\u00f6k\u00e7e","family":"Kenar-Art\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-6831","authenticated-orcid":false,"given":"Lykke","family":"Midtb\u00f8ll \u00d8rnbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.01.014_bib0001","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","article-title":"Quality of life in psoriatic arthritis","volume":"14","author":"Gudu","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ero.2026.01.014_bib0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41584-019-0256-0","article-title":"Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions","volume":"15","author":"Ferguson","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0003","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","article-title":"European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update","volume":"75","author":"Gossec","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0004","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/annrheumdis-2017-212687","article-title":"Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study","volume":"77","author":"Mease","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002939","article-title":"Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study","volume":"9","author":"Coates","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.01.014_bib0006","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/acr.24560","article-title":"Real-world six- and twelve-month drug retention, remission, and response rates of secukinumab in 2,017 patients with psoriatic arthritis in thirteen European Countries","volume":"74","author":"Michelsen","year":"2022","journal-title":"Arthritis Care Res (Hoboken.)"},{"key":"10.1016\/j.ero.2026.01.014_bib0007","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/keac403","article-title":"Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization","volume":"62","author":"Zhao","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.01.014_bib0008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ero.2026.01.014_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/1744666X.2019.1543591","article-title":"The relationship between smoking, psoriasis and psoriatic arthritis","volume":"15","author":"Pezzolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ero.2026.01.014_bib0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaad.2020.08.060","article-title":"Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational studies","volume":"84","author":"Xie","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","article-title":"2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases","volume":"82","author":"Gwinnutt","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ero.2026.01.014_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ard.2025.10.002","article-title":"EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis","volume":"85","author":"Marzo-Ortega","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ero.2026.01.014_bib0015","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s10067-020-05319-6","article-title":"Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review","volume":"40","author":"Zurita Prada","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0016","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1136\/annrheumdis-2014-205389","article-title":"Association between tobacco smoking and response to tumour necrosis factor \u03b1 inhibitor treatment in psoriatic arthritis: results from the DANBIO registry","volume":"74","author":"H\u00f8jgaard","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0017","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/14712598.2020.1761957","article-title":"One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study","volume":"20","author":"Chimenti","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ero.2026.01.014_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001519","article-title":"Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study","volume":"7","author":"Ramonda","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.01.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002303","article-title":"Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial","volume":"8","author":"Baraliakos","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.01.014_bib0020","article-title":"Multicenter study of secukinumab survival and safety in spondyloarthritis and psoriatic arthritis: SEcukinumab in Cantabria and ASTURias Study","volume":"8","author":"Alonso","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ero.2026.01.014_bib0021","article-title":"Association of gender, diagnosis, and obesity with retention rate of secukinumab in spondyloarthropathies: results form a multicenter real-world study","volume":"8","author":"Garc\u00eda-Dorta","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ero.2026.01.014_bib0022","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1159\/000522008","article-title":"Secukinumab drug survival in psoriasis and psoriatic arthritis patients: a 24-month real-life study","volume":"238","author":"Ortolan","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.ero.2026.01.014_bib0023","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/rheumatology\/kez427","article-title":"Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA","volume":"59","author":"Brahe","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.01.014_bib0024","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-023-03184-7","article-title":"Commonalities and differences in set-up and data collection across European spondyloarthritis registries \u2014 results from the EuroSpA collaboration","volume":"25","author":"Linde","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2026.01.014_bib0025","article-title":"Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey","volume":"8","author":"Ahmadzay","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.ero.2026.01.014_bib0026","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology."},{"key":"10.1016\/j.ero.2026.01.014_bib0027","unstructured":"Cosentyx, European Medicines Agency (EMA) [Internet]. [cited 2024 Sept 18]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cosentyx"},{"key":"10.1016\/j.ero.2026.01.014_bib0028","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/annrheumdis-2018-213463","article-title":"Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?","volume":"77","author":"Michelsen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0029","unstructured":"United Nations. National accounts\u2014analysis of main aggregates [Internet]. [cited 2024 Dec. 13]. Available from: https:\/\/unstats.un.org\/unsd\/snaama\/Basic"},{"key":"10.1016\/j.ero.2026.01.014_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/annrheumdis-2021-221477","article-title":"Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study","volume":"81","author":"Mongin","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0031","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030444","article-title":"Retention rate of secukinumab in psoriatic arthritis: real-world data results from a Spanish multicenter cohort","volume":"101","author":"Valero-Exp\u00f3sito","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ero.2026.01.014_bib0032","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10067-014-2742-8","article-title":"Smoking is associated with a worse self-reported health status in patients with psoriatic arthritis: data from a Swedish population-based cohort","volume":"34","author":"Bremander","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021896","article-title":"Lifetime cigarette smoking and chronic widespread and regional pain in later adulthood: evidence from the 1946 British birth cohort study","volume":"8","author":"Bendayan","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ero.2026.01.014_bib0034","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11916-022-01060-8","article-title":"The impact of smoking on the development and severity of chronic pain","volume":"26","author":"Robinson","year":"2022","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.ero.2026.01.014_bib0035","article-title":"Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases","volume":"9","author":"Roelsgaard","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ero.2026.01.014_bib0036","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1136\/annrheumdis-2020-217251","article-title":"Secukinumab efficacy in patients with PsA is not dependent on patients\u2019 body mass index","volume":"81","author":"Pantano","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.01.014_bib0037","first-page":"69","article-title":"The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort","volume":"42","author":"Ruscitti","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1203372","article-title":"Interleukin-17-targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile","volume":"14","author":"Queiro","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2026.01.014_bib0039","first-page":"49","article-title":"Overweight and obesity affect clinical assessment of synovitis in rheumatoid arthritis: comparison of ultrasonography and clinical exam","volume":"37","author":"Goossens","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40744-025-00758-6","article-title":"The relationship between metabolic syndrome and pain catastrophizing in psoriatic arthritis","volume":"12","author":"Currado","year":"2025","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.ero.2026.01.014_bib0041","article-title":"The obesity-inflammation axis in psoriatic disease: mechanisms and therapeutic strategies","author":"Haberman","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0042","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.ero.2026.01.014_bib0043","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/obr.12003","article-title":"Obesity and C-reactive protein in various populations: a systematic review and meta-analysis","volume":"14","author":"Choi","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.ero.2026.01.014_bib0044","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/acr.23229","article-title":"Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis","volume":"69","author":"George","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ero.2026.01.014_bib0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40744-024-00666-1","article-title":"Efficacy and safety of secukinumab in US patients with psoriatic arthritis: a subgroup analysis of the phase 3 FUTURE studies","volume":"11","author":"Kivitz","year":"2024","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.ero.2026.01.014_bib0046","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3899\/jrheum.210912","article-title":"Secukinumab in United States biologic-na\u00efve patients with psoriatic arthritis: results from the randomized, placebo-controlled CHOICE study","volume":"49","author":"Nguyen","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ero.2026.01.014_bib0047","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1403494818761971","article-title":"A comparison of measured versus self-reported anthropometrics for assessing obesity in adults: a literature review","volume":"46","author":"Maukonen","year":"2018","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ero.2026.01.014_bib0048","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body mass index: obesity, BMI, and health: a critical review","volume":"50","author":"Nuttall","year":"2015","journal-title":"Nutr Today"},{"key":"10.1016\/j.ero.2026.01.014_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237598","article-title":"Psoriatic disease and body composition: a systematic review and narrative synthesis","volume":"15","author":"Blake","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ero.2026.01.014_bib0050","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.181089","article-title":"Endorsement of the 66\/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 psoriatic arthritis workshop report","volume":"46","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"J Rheumatol"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:54:23Z","timestamp":1787716463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3050708126000145"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.01.014","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}